Oppenheimer analyst issues OUTPERFORM recommendation for INO on March 13, 2026 11:08AM ET. The previous analyst recommendation was Outperform.INO was trading at $1.68 at issue of the analyst recommendation.The overall...
Benchmark analyst issues SPECULATIVE BUY recommendation for HBIO on March 13, 2026 11:08AM ET. The previous analyst recommendation was Speculative Buy.HBIO was trading at $0.494 at issue of the analyst...
Cantor Fitzgerald analyst issues OVERWEIGHT recommendation for CRVS on March 13, 2026 11:23AM ET. The previous analyst recommendation was Overweight.CRVS was trading at $16.01 at issue of the analyst recommendation.The...
Cantor Fitzgerald analyst issues OVERWEIGHT recommendation for CAPR on March 13, 2026 11:30AM ET. The previous analyst recommendation was Overweight.CAPR was trading at $33.42 at issue of the analyst recommendation.The...
Jefferies analyst issues BUY recommendation for FHTX on March 12, 2026 08:44PM ET. The previous analyst recommendation was Buy.FHTX was trading at $4.92 at issue of the analyst recommendation.The overall...
Leerink Partners analyst issues OUTPERFORM recommendation for TNYA on March 12, 2026 02:37PM ET. The previous analyst recommendation was Outperform.TNYA was trading at $0.907 at issue of the analyst recommendation.The...
Benchmark analyst issues BUY recommendation for TATT on March 12, 2026 12:34PM ET. The previous analyst recommendation was Buy.TATT was trading at $56.39 at issue of the analyst recommendation.The overall...
Cowen & Co. analyst issues BUY recommendation for NBTX on March 12, 2026 01:31PM ET. The previous analyst recommendation was Buy.NBTX was trading at $31.9394 at issue of the analyst...
Cantor Fitzgerald analyst issues OVERWEIGHT recommendation for CMPX on March 12, 2026 01:32PM ET. The previous analyst recommendation was Overweight.CMPX was trading at $5.265 at issue of the analyst recommendation.The...
Cantor Fitzgerald analyst issues OVERWEIGHT recommendation for CDXS on March 12, 2026 01:41PM ET. The previous analyst recommendation was Overweight.CDXS was trading at $1.695 at issue of the analyst recommendation.The...
